Expression of MHC I and NK ligands on human CD133⁺ glioma cells: possible targets of immunotherapy

By Wu Anhua   Wiesner Steve   Xiao Jing   Ericson Katya   Chen Wei   Hall Walter   Low Walter   Ohlfest John  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 121-131

Springer Publishing Company

Access to resources Recommend Favorite

CD133 expression in osteosarcoma and derivation of CD133+ cells

By                

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 577-584

Spandidos Publications

Access to resources Recommend Favorite

CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells

By              

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 1011-1017

Spandidos Publications

Access to resources Recommend Favorite

miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells

By                  

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 869-877

Spandidos Publications

Access to resources Recommend Favorite

The Ultrastructural Difference between CD133-positive U251 Glioma Stem Cells and Normal U251 Glioma Cells

By Yang Bo   Wang You   Yang Chunxu   Ouyang Wen   Zhou Fuxiang   Zhou Yunfeng   Xie Conghua  

Ultrastructural Pathology, Vol. 36, Iss. 6, 2012-12 ,pp. : 404-408

Informa Healthcare

Access to resources Recommend Favorite